Fordyce Marshall
PRESIDENT AND CEO, Director
5 filings on record here, covering VERA, BFA, BFB. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-12
| Exercise | VERA | Vera Therapeutics, Inc. | $53,591 |
| Sell | VERA | Vera Therapeutics, Inc. | $520,978 |
| Sell | VERA | Vera Therapeutics, Inc. | $158,769 |
| Exercise | VERA | Vera Therapeutics, Inc. | |
CORPORATEFiled 2026-08-12
| Exercise | VERA | Vera Therapeutics, Inc. | $53,591 |
| Sell | VERA | Vera Therapeutics, Inc. | $698,387 |
| Sell | VERA | Vera Therapeutics, Inc. | $3,382 |
| Exercise | VERA | Vera Therapeutics, Inc. | |
CORPORATEFiled 2026-08-12
| Exercise | VERA | Vera Therapeutics, Inc. | $133,977 |
| Sell | VERA | Vera Therapeutics, Inc. | $40,776 |
| Sell | VERA | Vera Therapeutics, Inc. | $1,369,496 |
| Sell | VERA | Vera Therapeutics, Inc. | $450,007 |
| Sell | VERA | Vera Therapeutics, Inc. | $95,908 |
| Exercise | VERA | Vera Therapeutics, Inc. | |
CORPORATEFiled 2026-07-24
| Award | BFA, BFB | BROWN FORMAN CORP | |
CORPORATEFiled 2026-06-24
| Sell | VERA | Vera Therapeutics, Inc. | $698,387 |
| Sell | VERA | Vera Therapeutics, Inc. | $3,382 |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.